Abstract:Mycobacterium bovis is the causative agent of bovine tuberculosis (bTB). The proteins Ag85B, MPB64, and ESAT-6 are the major immunogenic antigens of M. bovis; these proteins play important roles in inducing immune responses that confer resistance against infections. In the present study, we used pcDNA3.1(+) as a vector and constructed various DNA vaccines with the genes encoding the three antigens mentioned above. This procedure involved the following steps: fusion of two genes (pcDNA-MPB64-Ag85B, pcMA), fusion of three genes (pcDNA-MPB64-Ag85B-ESAT-6, pcMAE), bivalent combinations (pcDNA-Ag85B+pcDNA-MPB64, pcA+M), and trivalent combinations (pcDNA-Ag85B+pcDNA-MPB64+pcDNA-ESAT-6, pcA+M+E). The immune response to the DNA vaccines was evaluated based on serum antibody titers, lymphocyte proliferation assay, and titers of the cytokines interferon-γ (IFN-γ) and interleukin-2 (IL-2). The protective efficacy following challenge with a virulent M. bovis strain, C68001, was evaluated based on survival rate, bacterial loads in lung tissue, and histopathologic changes. A significant 2-fold increase in serum antibody levels was observed in mice vaccinated with fusion DNA (two or three genes). Furthermore, the lymphocyte proliferation (SI) values and the levels of IFN-γ and IL-2 were higher in mice vaccinated with fusion DNA (two or three genes) than in those immunized with polyvalent combination DNA vaccines (P<0.05). Additionally, the fusion DNA vaccines provided protection that was superior to that provided by the polyvalent combination DNA vaccines following challenge with M. bovis strain C68001. The protective efficacy of the fusion DNA vaccines in mice immunized three times was equivalent to the protective efficacy in mice immunized once with the Bacillus Calmette–Guerin (BCG) vaccine. This suggests that fusion DNA vaccine represent a promising approach for the prevention of bTB.

A Combined DNA Vaccine-Prime, BCG-boost Strategy Results in Better Protection Against Mycobacterium Bovis Challenge.

A DNA Prime- <i>Mycobacterium bovis</i> BCG Boost Vaccination Strategy for Cattle Induces Protection against Bovine Tuberculosis

A Dna Prime-Mycobactetium Bovis Bcg Boost Vaccination Strategy For Cattle Induces Protection Against Bovine Tuberculosis

Combined DNA Vaccines Formulated Either in DDA or in Saline Protect Cattle from Mycobacterium Bovis Infection

A combined DNA vaccine provides protective immunity against Mycobacterium bovis and Brucella abortus in cattle.

Heterologous prime-boost BCG with DNA vaccine expressing fusion antigens Rv2299c and Ag85A improves protective efficacy against Mycobacterium tuberculosis in mice

The Mycobacterium Bovis BCG Prime-Rv0577 DNA Boost Vaccination Induces a Durable Th1 Immune Response in Mice.

Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.

The Order of Prime-Boost Vaccination of Neonatal Calves with Mycobacterium Bovis Bcg and A Dna Vaccine Encoding Mycobacterial Proteins Hsp65, Hsp70, and Apa is Not Critical for Enhancing Protection Against Bovine Tuberculosis

Improved Immunogenicity of DNA Vaccination with Mycobacterial HSP65 Against Bovine Tuberculosis by Protein Boosting

A Heterologous DNA Priming-Mycobacterium Bovis BCG Boosting Immunization Strategy Using Mycobacterial Hsp70, Hsp65, and Apa Antigens Improves Protection Against Tuberculosis in Mice.

A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice

Effective DNA vaccination of cattle with the mycobacterial antigens MPB83 and MPB70 does not compromise the specificity of the comparative intradermal tuberculin skin test

Enhanced Protective Efficacy Against Mycobacterium Tuberculosis Afforded by BCG Prime‐dna Boost Regimen in an Early Challenge Mouse Model is Associated with Increased Splenic Interleukin‐2‐producing CD4 T‐cell Frequency Post‐vaccination

A Combined DNA Vaccine Enhances Protective Immunity Against Mycobacterium Tuberculosis and Brucella Abortus in the Presence of an IL-12 Expression Vector

Boosting BCG-primed Mice with Chimeric DNA Vaccine HG856A Induces Potent Multifunctional T Cell Responses and Enhanced Protection Against Mycobacterium Tuberculosis

Increased B and T Cell Responses in M. bovis Bacille Calmette-Guérin Vaccinated Pigs Co-Immunized with Plasmid DNA Encoding a Prototype Tuberculosis Antigen

Heterologous Boosting with Recombinant Vsv-846 in Bcg-Primed Mice Confers Improved Protection Against Mycobacterium Infection

Ag85A DNA Vaccination Boosting Enhances BCG Primed-Mice Anti-Tuberculosis T Cell Responses

Combined Recombinant DNA Vaccine Results in Significant Protection Against Mycobacterium Tuberculosis

Protection of Mice with a Divalent Tuberculosis DNA Vaccine Encoding Antigens Ag85B and MPT64